🌙 Tirzepatide (Zepbound) Offers New Hope for Sleep Apnea Patients with Obesity

🧠 What Is Obstructive Sleep Apnea (OSA)?

Obstructive sleep apnea (OSA) is a common but serious sleep disorder that causes repeated breathing interruptions during sleep. It can lead to:

• Loud snoring

• Choking or gasping at night

• Daytime fatigue

• Increased risk of heart attack and stroke

👉 OSA affects approximately 39 million adults in the U.S., many of whom are undiagnosed.

❗ OSA is an independent cardiovascular risk factor—meaning it increases your risk of heart disease even if you’re otherwise healthy.

💡 CPAP and Other Treatments: Helpful, But Not Enough

• CPAP (Continuous Positive Airway Pressure) is the standard treatment—but many people find it uncomfortable or stop using it.

• CPAP does not reduce cardiovascular risk despite improving sleep quality.

• Mandibular devices (oral appliances) may help in mild cases, but they typically don’t work for moderate-to-severe OSA.

• Inspire® surgery is an option for some patients, but insurance often requires a BMI under 35.

🚀 New Breakthrough: The SURMOUNT-OSA Trials

Researchers studied a new medication called tirzepatide (Zepbound) in a large clinical trial known as SURMOUNT-OSA.

📊 In over 450 adults with OSA and obesity:

• Tirzepatide reduced breathing interruptions by 25–29 events per hour.

• Participants lost significant weight.

• Blood pressure and inflammation improved.

🧬 Zepbound was FDA-approved in December 2024 as the first drug specifically for OSA in adults with obesity.

📉 Why This Matters

• OSA symptoms improved significantly

• Weight loss may help reverse the root cause

• Potential cardiovascular benefits, unlike CPAP alone

💊 Insurance Coverage

✅ Medicare and many insurance plans cover tirzepatide when prescribed for moderate-to-severe OSA in adults with obesity.🧾 Inspire surgical treatment usually requires a BMI < 35 for insurance approval, even though FDA approval goes up to 40.

💬 Should You Talk to Your Doctor?

If you:

• Struggle with CPAP

• Have obesity-related OSA

• Want to reduce cardiovascular risk…

📞 Talk to Dr. Sutherland or Melanie at Rainier Medical about tirzepatide as part of your treatment plan. If needed, we can order or update your sleep study, write a prescription, obtain a prior authorization, and make sure you get the best health outcome.

😴 A better night’s sleep—and better long-term health—could finally be within reach.

Take Back Your Sleep,

Valerie Hope-Slocum Sutherland, MD